The five-year study, which has not yet been peer-reviewed, looks at how nanoparticles can be used to deliver slow-releasing pain medication to the inside of the knee. Researchers hope the technology would allow the 30 million Americans who have osteoarthritis to get injections every few months instead of every week to manage pain.
Related Articles about Pain Management:
Col. Kevin Galloway: Army Needs Multi-Pronged Approach to Pain Management
Study: Inflammation Is Controlled Differently in Brain and Other Tissues
Study: Yoga, Stretching Ease Chronic Back Pain
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
